Vaxcyte’s stock dips after biotech completes $1.42 billion stock offering

By September 6, 2024No Comments1 Min Read

Vaxcyte Inc.’s stock fell 3% early Friday, after the company completed a stock offering that is expected to generate $1.42 billion in proceeds.

Please leave this field empty

Oh hi there 👋
It’s nice to meet you.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

September 20, 2024

September 20, 2024

September 20, 2024